LEONARD ROSS

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

EyePoint Pharmaceuticals, Inc.

Filing Date Source Excerpt
2017-05-15 Leonard Ross 180,300 shares * beneficial ownership.
2018-05-11 Leonard Ross 258,632 *

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-25